Search
Upadacitinib per al tractament de l’artritis reumatoide de moderada a greu
(2021-03-03)
Rheumatoid arthritis (RA) is an inflammatory disease of autoimmune etiology characterized by chronic inflammation of the synovial membrane, which leads to the progressive destruction of joint structures. Typical symptoms ...
Axicabtagen ciloleucel i tisagenlecleucel per al tractament del limfoma B de cèl·lules grans
(2019-03-21)
Axicabtagen ciloleucel and tisagenlecleucel are two gene therapies that contain
T-lymphocytes of the patient previously manipulated so they express themselves
membrane, chimeric antigenic receptor or CAR. This receiver ...
Sorafenib i lenvatinib per al tractament en primera línia del carcinoma hepatocel·lular (CHC)
(2020-07-29)
Hepatocellular carcinoma (HCC) is the most common primary liver cancer, the fifth most common cancer in men and the seventh in women, and is associated with high mortality, which is the third leading cause of cancer death. ...
Informe Seguiment Gestants
(2020-05-18)
This report collects data on pregnant women with COVID-19 and reported manually in the registration of the Portalof Applications - "COVID-19 - Registry of pregnant patients of theSCOG (Catalan Society of Obstetric s and ...
Patiròmer i ciclosilicat de sodi i zirconi per al tractament de la hiperpotassèmia
(2021-05-06)
Serum potassium levels (K-S) are normally maintained within narrow limits (3.5-5.0 mmol / L) by multiple mechanisms. Such strict regulation is essential for numerous cellular processes. Imbalances in potassium (K) homeostasis ...